Cui, Yingzi
Lyu, Xuehui http://orcid.org/0000-0002-6185-1170
Ding, Li
Ke, Lan
Yang, Dechang
Pirouz, Mehdi http://orcid.org/0000-0002-7439-6066
Qi, Ye
Ong, Jennie
Gao, Ge http://orcid.org/0000-0001-6470-8815
Du, Peng
Gregory, Richard I. http://orcid.org/0000-0001-8090-8673
Article History
Received: 21 January 2020
Accepted: 8 April 2021
First Online: 5 May 2021
Competing interests
: The authors declare no competing interests. R.I.G is a co-founder and scientific advisory board member of 28/7 Therapeutics and Theon Therapeutics.